The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The Diabetes Quality Improvement Project
Open accessAbstract
BACKGROUND -As the worldwide diabetes epidemic continues to unfold, some experts have asked whether the war against it is being lost (1-3).In the U.S., blindness, kidney failure, amputations, and cardiovascular disease resulting from diabetes not only markedly reduce quality and length of life but also cost nearly $100 billion annually (4 -7).Fortunately, a vast body of research has clearly established that several effective treatments and practices may substantially reduce or prevent this burden (8 -19).These interventions, if broadly implemented, can allow us to use our health efforts and resources more effectively and efficiently to minimize the diabetes burden.Judging from the scant data available, however, the level of care currently delivered to populations with diabetes often may not produce the possible health-related gains (20,21).To assess more completely the level of diabetes care delivered in the U.S., we need standardized uniform performance measures that can assess quality of care accurately and reliably.These measures will enhance uptake of research into practice and may ultimately improve diabetes care and clinical outcomes.In the early to mid-1990s, many organizations developed performance measures for diabetes care, but the result was that providers were often required to collect and report many different, sometimes conflicting, measures, depending on their care delivery system.It was recognized that a national consensus on measures could enhance this process and provide a method for assessing care within and across health care settings while providing a meaningful mechanism for quality improvement (QI).In this review, we describe the Diabetes Quality Improvement Project (DQIP), which has developed and implemented a comprehensive set of national measures for evaluation and QI.HISTORY AND ORGANIZATIONAL STRUCTURE -In 1995, the Health Care Financing Administration (now known as the Centers for Medicare and Medical Services [CMS]) and the National Institute of Diabetes and Digestive and Kidney Diseases convened ϳ20 public and private health organizations with an interest in performance measurement for diabetes care (Fig. 1).The goal was to identify a strategy for developing a comprehensive measurement set for diabetes care that would be broadly accepted and widely implemented.Financial and logistical support were needed to create the DQIP, as was an organizational structure with broad representation from the private and public sectors as well as professional organizations, clinical and public health experts, diabetes researchers, and experts in methodology.In 1997, DQIP was founded jointly by CMS, the National Committee for Quality Assurance (NCQA), and the American Diabetes Association (ADA).CMS, which has long been committed to quality of care issues, provided financial support, and NCQA provided logistical support.An Operations Group was created of public and private sector organizations and agencies to provide general direction, and a Technical Expert Panel (TEP) was formed to develop quality performance measures.The organizational structure was designed to enhance nationwide adoption of the DQIP performance measures by giving the project scientific credibility, links to the medical community, and the commitment of organizations that pay for diabetes care.The Operations Group included the ADA, the Foundation for Accountability in Health Care (FACCT), CMS, NCQA, the American Academy of Family Practice (AAFP), the American College of Physicians-American Society of Internal Medicine (ACP-ASIM), the Centers for Disease Control and Prevention (CDC), and the Veterans Health Administration (VHA).Thus, the members included the majority of diabetes care providers in the U.S., the major health care organizations in which diabetes care is delivered, and the major payors for diabetes care, along with leading researchers in clinical diabetes and health services.Several of these organizations had already worked extensively on improving diabetes care, and many had developed specific quality measures.Each organization realized that joining DQIP
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
(2000) · PubMed · Cited by 2,095
Turner, R. D., & Holman, R. R. (1998) · Cited by 1,974
Pyörälä, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G., & The Scandinavian Simvastatin Survival Study (4S) Group (1997) · Diabetes Care · doi:10.2337/diacare.20.4.614 · Cited by 1,623
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Early Photocoagulation for Diabetic Retinopathy
(1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38011-7 · Cited by 1,259
Reichard, P., Nilsson, B.-Y., & Rosenqvist, U. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290502 · Cited by 1,202
Goldberg, R. B., Mellies, M. J., Sacks, F. M., Moyé, L. A., Howard, B. V., Howard, W. J., Davis, B. R., Cole, T. G., Pfeffer, M. A., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.23.2513 · Cited by 986
Curb, J. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540230036032 · Cited by 930
Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes
Klein, R. (1995) · Diabetes Care · doi:10.2337/diacare.18.2.258 · Cited by 845
Economic Consequences of Diabetes Mellitus in the U.S. in 1997
American Diabetes Association (1998) · Diabetes Care · doi:10.2337/diacare.21.2.296 · Cited by 652
Quality of Medical Care Delivered to Medicare Beneficiaries: A Profile at State and National Levels
Jencks, S. F., Cuerdon, T., Burwen, D. R., Fleming, B., Houck, P. M., Kussmaul, A. E., Nilasena, D. S., Ordin, D. L., & Arday, D. R. (2000) · JAMA · doi:10.1001/jama.284.13.1670 · Cited by 647
Self-citationKassoff, A. (1992) · JAMA · doi:10.1001/jama.1992.03490100090033 · Cited by 481
Litzelman, D. K., Slemenda, C. W., Langefeld, C. D., Hays, L. M., Welch, M. A., Bild, D. E., Ford, E. S., & Vinicor, F. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-1-199307010-00006 · Cited by 398
Eastman, R. C., Javitt, J. C., Herman, W. H., Dasbach, E. J., Copley-Merriman, C., Maier, W., Dong, F., Manninen, D., Zbrozek, A. S., Kotsanos, J., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.735 · Cited by 333
Ravid, M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440030080010 · Cited by 314
Population-Based Assessment of the Level of Care Among Adults With Diabetes in the U.S
Beckles, G. L., Engelgau, M. M., Narayan, K. V., Herman, W. H., Aubert, R. E., & Williamson, D. F. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1432 · Cited by 293
Self-citationEstimated benefits of glycemic control in microvascular complications in type 2 diabetes
Vijan, S., Hofer, T. P., & Hayward, R. A. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-9-199711010-00003 · Cited by 228 · cited 2×
“, hypertension) can diminish the benefits of aggressive glycemic control (28,29).”
BackgroundCurb, J. D. (1996) · JAMA · doi:10.1001/jama.276.23.1886 · Cited by 161
The Contribution of Non—Insulin-Dependent Diabetes to Lower-Extremity Amputation in the Community
Humphrey, L. L. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420080085009 · Cited by 101
How Should We Respond to the Worldwide Diabetes Epidemic?
Clark, C. M. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.475 · Cited by 47
Cited by
Association of Health Literacy With Diabetes Outcomes
Schillinger, D. (2002) · JAMA · doi:10.1001/jama.288.4.475 · Cited by 1,938
Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes
Saydah, S. H. (2004) · JAMA · doi:10.1001/jama.291.3.335 · Cited by 1,357
Brown, A. F. (2004) · Epidemiologic Reviews · doi:10.1093/epirev/mxh002 · Cited by 606
A Diabetes Report Card for the United States: Quality of Care in the 1990s
Saaddine, J. B., Engelgau, M. M., Beckles, G. L., Gregg, E. W., Thompson, T. J., & Narayan, K. M. V. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00005 · Cited by 589
Self-citationImprovements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988–2002
Saaddine, J. B., Cadwell, B., Gregg, E. W., Engelgau, M. M., Vinicor, F., Imperatore, G., & Narayan, K. M. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-7-200604040-00005 · Cited by 571
Self-citation
Metadata
- Authors
- Fleming, B. B., Greenfield, S., Engelgau, M. M., Pogach, L. M., Clauser, S. B., Parrott, M. A., & For the DQIP Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2001-10-01
- Volume
- 24
- Issue
- 10
- Pages
- 1815-1820
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2146602330
- Cited by
- 287
- References
- 30
- FWCI
- 42.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.